- A study of 2.3 million patients found mRNA COVID-19 vaccine recipients had a 30% higher risk of thyroid disorders (e.g., hypothyroidism) compared to unvaccinated individuals, with over 4,000 extra hypothyroidism cases observed. Those who received only one dose faced double the risk.
- The study suggests mRNA vaccines may trigger autoimmune reactions, where the immune system attacks thyroid tissue, mirroring concerns seen with other conditions like myocarditis and hepatitis. The Johnson & Johnson vaccine (non-mRNA) showed no elevated thyroid risks, pointing to mRNA-specific effects.
- Thyroid dysfunction can lead to chronic metabolic issues (weight gain, high cholesterol, cardiovascular stress). Researchers warn of slow-progressing symptoms that may be overlooked, emphasizing the need for post-vaccination thyroid monitoring.
- Despite robust methodology (1.16 million vaccinated vs. unvaccinated matched controls), the study received little mainstream attention, reflecting broader challenges in addressing vaccine safety concerns transparently.
- The findings highlight the need for long-term safety evaluations of mRNA technology, especially as it expands into annual boosters and flu vaccines. Critics argue crisis-driven approvals bypassed standard long-term trials, risking unintended health consequences.
(Natural News)—A groundbreaking study of over 2.3 million patients has found that recipients of mRNA-based COVID-19 vaccines face a significantly higher risk of developing thyroid disease than unvaccinated individuals, raising urgent questions about the lasting health consequences of pandemic-era shots. Published in January 2024 but only recently highlighted by researchers, the analysis—led by scientists at National Taiwan University—reveals that vaccinated individuals were 30% likelier to be diagnosed with thyroid disorders a year later, with over 4,000 extra cases of hypothyroidism alone in the study group. Even more striking, people who received only one dose of an mRNA vaccine had nearly double the risk of hypothyroidism compared to unvaccinated peers. These findings add urgency to ongoing debates about the long-term safety of mRNA technology amid a growing body of research linking vaccines to autoimmune conditions, including myocarditis and hepatitis.
The study’s key findings: A statistical wake-up call
The Taiwanese researchers used the TriNetX medical records database, covering 116 million patients, to track outcomes for 1.16 million vaccinated individuals and an equal number of unvaccinated, medically matched controls from January 2022 to December 2023. The results were stark:
- Hypothyroidism risks: Over 4,000 extra cases of hypothyroidism were observed in the vaccinated group after one year, with hazard ratios (a measure of relative risk) ranging from 1.14 to 1.30 for the condition. The gap between vaccinated and unvaccinated patients widened steadily over time.
- Hyperthyroidism paradox: While vaccinated individuals initially showed reduced hyperthyroidism rates between 3–9 months post-vaccination, this trend faded by 12 months, suggesting transient suppression followed by later complications. Among mRNA recipients specifically, hyperthyroidism risks also rose at 12 months, indicating further complexity.
- Single-dose subgroup: Those who received only one mRNA dose faced the highest risks, with hypothyroidism cases doubling and hyperthyroidism increasing by 25%. This finding may reflect heightened immune responses in persons less likely to tolerate multiple injections.
Lead author Dr. Chen-Min Liang, a thyroid specialist at National Taiwan University, emphasized the statistical rigor of the study: “Our sample size and matching protocols minimized confounding factors. These risks are unlikely coincidental.” The study also compared outcomes for recipients of the lesser-studied Johnson & Johnson (Ad26) vaccine, which did not correlate with elevated thyroid risks, strengthening suspicions about mRNA-specific mechanisms.
Autoimmune concerns and broader implications
The thyroid’s role in regulating metabolism makes even moderate dysfunction a hidden health drain, sapping energy and contributing to weight gain, high cholesterol and cardiovascular stress. The study’s authors note that mRNA vaccines, which instruct immune cells to produce SARS-CoV-2 spike proteins, may trigger autoimmune reactions — where the immune system mistakenly targets bodily tissues — such as those seen in multiple sclerosis, Type 1 diabetes and hypothyroidism.
This thyroid data follows years of scattered reports associating mRNA shots with autoimmune hepatitis, myocarditis and rare neurological disorders. The U.S. Centers for Disease Control and Prevention (CDC), for instance, has acknowledged a “high verification rate” of myocarditis cases after mRNA vaccinations, with higher risks noted for adolescents and young adults. Such harms, critics argue, justify closer scrutiny of population-level post-vaccination outcomes.
Dr. Patricia Fitzgerald, an immunologist at the University of California, San Francisco, who was not involved in the study, noted: “The thyroid is a classic target in autoimmune disorders. If mRNA mechanisms prime the immune system to cross-react with thyroid tissue, that’s a red flag for chronic health impacts.”
A call for vigilance in an era of scientific uncertainty
The Taiwanese study’s near-total obscurity in mainstream media highlights both the challenges of communicating difficult science and the uneven playing field facing researchers who question vaccine safety. As of May 2025, the paper had received limited attention despite its publication in a major journal — a pattern authors attribute to systemic reluctance to scrutinize widely deployed public health tools.
Meanwhile, broader population trends hint at unsolved puzzles. Data from the CDC and other agencies show elevated mortality in several high-income nations with high mRNA uptake, even as pandemic deaths dwindle. While not definitively linked to vaccines, lingering autoimmune effects like thyroid dysfunction could contribute to such trends by worsening chronic conditions over years.
As nations grapple with mandates for annual booster shots and mRNA-based flu vaccines, the study underscores why transparency matters: Thyroid disorders often progress slowly, with symptoms dismissed as stress or aging before a definitive diagnosis. In that light, the researchers’ call for “ongoing thyroid function monitoring” after mRNA vaccination now feels less like a technical recommendation and more like a plea for caution.
The mRNA vaccine safety debate
The current controversy mirrors past public health disputes over vaccines and medications. The 1950s polio vaccine’s rollout, for instance, sparked early debates about rare but serious adverse events, spurring improvements in safety protocols. Similarly, modern mRNA technology’s rapid deployment during the pandemic sidestepped decades of standard pre-approval trials, leaving unresolved questions about long-term effects especially in non-pandemic settings.
Today’s studies, often published in obscure journals or sidelined by mainstream discourse, reflect a broader struggle over science communication. As more data emerge, the challenge becomes clear: Balancing pandemic-era urgency with the ethics of informed consent demands fearless scrutiny of mRNA’s collateral health costs, even as the world moves forward.
The unfinished journey toward vaccine transparency
This study does not condemn mRNA vaccines as inherently dangerous. But it does demand answers — especially given their now-widespread use beyond emergency settings. If thyroid risks emerge as just one facet of long-term immune disruption, future generations may look back on the 2020s as a moment when scientific humility collided with crisis-driven mandates. Whether openness prevails over complacency could determine how millions of lives unfold, one gland at a time.
Sources for this article include:
Bypass Big Tech Censors
Two Storms, One Harvest
Every food crisis in living memory has been a one-shock event. The 2008 price spike was a commodity bubble. The 2020 shortages were a logistics failure. The 2022 grain scare was a war on one exporter’s ports. Each time, the system bent, adjusted, and recovered, and each time the experts assured us afterward that global markets are simply too big and too diversified to fail.
What nobody in Washington seems eager to discuss is that 2026 is shaping up to be something the modern food system has never actually faced. Two independent shocks, one climatic and one geopolitical, are converging on the same harvest cycle at the same time. Not sequentially. Simultaneously.
Start with the weather. The Pacific Ocean is currently building toward what forecasters now openly call a record event. NOAA’s Climate Prediction Center puts the odds of at least a strong El Niño near 88 percent, with roughly two in three odds it reaches “very strong” status, the tier reserved for perhaps three or four events in the entire satellite era. Every major global model now projects a median peak in Super El Niño territory, and most of them project it exceeding the 2015-16 event, which until now held the modern record. Sea surface anomalies were already brushing the super threshold in mid-July, months before these events normally peak. The atmosphere has already shifted into El Niño mode, and the event is forecast to crest in late fall and early winter.
This is not about “climate change.” It’s about the standard cycles of weather, and the cycle we’re currently in is one that has likely devastated societies in the past. We’re better prepared as a society today, but not all Americans are equally prepared.
Serious households have started doing the quiet math on their own. Grocery bills tell part of the story, and the forecast maps tell the rest, which is why long-term food storage has moved from fringe hobby to mainstream line item in the family budget, with established suppliers like Heaven’s Harvest seeing demand from people who five years ago would have rolled their eyes at the idea. That instinct is not paranoia. It is pattern recognition, and the pattern is worth walking through carefully.
Editor’s Note: Heaven’s Harvest IS a sponsor, but the warnings of this article are real and would be written even if we didn’t have a survival food sponsor. With that said, those who take advantage of what they offer can use promo code “Patriot” for 15% off.
The Fertilizer Clock Is Already Running
While the Pacific warms, the second shock has been unfolding in the Strait of Hormuz. The conflict with Iran turned the world’s most important energy chokepoint into a contested waterway, and the consequences reach far beyond the gas pump. Roughly a third of global fertilizer trade moves through Hormuz, and the disruption sent urea prices up 86 percent year over year by March, with a 53 percent jump in a single month.
The World Bank projects energy prices rising about 24 percent in 2026 and fertilizer about 31 percent. By its own accounting, fertilizer prices ran 35 percent higher in the first five months of this year than the same period last year.
Here is the mechanism the nightly news will not explain. Fertilizer is not a grocery item. It is a time-delayed input. The nitrogen a farmer in Iowa or Punjab could not afford to apply this spring does not show up as a problem this spring. It shows up as a thinner harvest six to twelve months later.
The World Bank’s own food security brief concedes that the effects of reduced applications earlier this season “are likely to become visible only later in harvest outcomes.” Translate that from institutional language into plain English and it means this. The damage is already done, it is already in the ground, and we are simply waiting for it to arrive on the shelf.
Now check the calendar. Six to twelve months from the spring planting season lands us squarely in late 2026 and early 2027. Which is precisely when the strongest El Niño in the instrumental record is forecast to peak, bringing its signature droughts to Southeast Asia, Australia, southern Africa, northern Brazil, and South Asia, the very regions that grow the world’s rice, sugar, and oilseeds.
The World Bank warns openly that a strong El Niño “could disrupt multiple crop belts simultaneously” on top of the conflict-driven input costs. Their baseline projection assumes the Middle East disruptions ease by autumn. What in the last two years of Middle East history suggests that assumption is safe?
The System Has No Slack Left
The comfortable answer is that global markets always adjust. But adjustment requires slack, and the slack is gone. Global cereal production is expected to decline from last year’s records even before El Niño does its work. The UN World Food Programme, hardly a den of right-wing preppers, is calling this the most significant disruption to its supply chains since Covid and the invasion of Ukraine, and its supply chain director put the stakes bluntly.
Today’s supply chain challenges are tomorrow’s hunger crisis.
There is also a political dimension that markets cannot price. When food gets scarce, governments do not behave like economists. They behave like politicians. Export bans, hoarding mandates, and panic buying at the national level turned the modest rice shortfall of 2008 into a global crisis, and analysts are already warning that import-dependent nations are the first dominoes.
The 2015-16 Super El Niño, a far weaker event than what is now forecast, threw tens of millions into food stress across Africa and Asia. This one is projected to be stronger, and it arrives with fertilizer already rationed by price and shipping lanes already contested by missiles.
What Joseph Knew
Scripture does not treat preparation for lean years as faithlessness. It treats it as wisdom delivered in advance to those willing to act on it.
Behold, there come seven years of great plenty throughout all the land of Egypt: And there shall arise after them seven years of famine; and all the plenty shall be forgotten in the land of Egypt.
Joseph did not respond to that warning with a hashtag or a committee. He stored grain during the years of abundance, and when the famine came, Egypt stood while its neighbors begged. The lesson is not that famine is certain. It is that the time to prepare is precisely when preparation still looks optional.
Nobody who filled a pantry in a year of plenty has ever regretted it, and nobody standing in an empty aisle has ever been glad he waited for certainty.
None of this calls for panic, and panic is the enemy of sound judgment anyway. It calls for the same unglamorous prudence our grandparents considered ordinary. Keep some cash margin, know your local growers, and put real food in deep storage while it is cheap and available, because the entire arc of this story is that cheap and available is a closing window.
Families looking for a straightforward place to start can visit Heaven’s Harvest and use promo code Patriot for 15 percent off long-term storable food. The forecasts may yet soften, the strait may yet reopen, and we should pray they do. But hope is a fine thing to hold and a foolish thing to eat.